Organ Transplant Company Paragonix Technologies Raises $24M+ in Digital Health Funding
Organ transplant company Paragonix Technologies has secured $24 million in Series B funding led by Signet Healthcare Partners.
The company has developed three FDA-cleared and CE-marked devices – Paragonix SherpaPak, LUNGguard Donor Lung Preservation System and the LIVERguard system – that incorporate digital tracking and communication technologies for organ tracking, reporting and monitoring.
The company will use this investment to expand its commercial footprint, including its clinical service offerings and inventory, and advance its transplantation innovations.
“This growth investment comes at a critical time as we strive to meet the growing demand for our organ preservation products. We are excited to rapidly advance our pipeline of innovations to improve our ability to preserve and safely transport as many donor organs as possible. We are thrilled to have Signet as a partner to accelerate growth and achieve our ambitious long-term strategic goals, and look forward to leveraging their extensive experience in the medical device market,” said Dr. Lisa Anderson, CEO of Paragonix Technologies, in a statement.
Shanghai-based SiYi Intelligence, which specializes in medical rehabilitation robots, has raised nearly $15 million in Series A funding.
Chengdu Bio-town Equity Investment Fund led the round, with participation from existing investor Tao Capital.
The company offers a robotic hand rehabilitation glove, EEG-based assistive brain-computer interfaces, an exoskeleton walking suit for lower extremity augmentation, and transcutaneous electrical nerve stimulation devices and accessories.
It will use the funds to accelerate research and development of its neurorehabilitation integration solutions and create its digital rehabilitation services platform.
Aiberry, an AI-backed mental health screening platform, secured $8 million in seed funding, bringing its total raise to $10 million.
Confluence Capital Group led the round with participation from Ascension AI.
Aiberry’s platform helps detect mental health disorders using conversations between an AI therapy assistant and the user, analyzing speech patterns and changes in facial expressions.
The Seattle-based company will use the funds to accelerate adoption of its platform.
“I would like to thank our investors, whose support allows us to quickly build trust between patients, consumers and providers by collaborating with psychiatrists, psychologists, social workers, licensed mental health counselors and other people who assess and treat mental health disorders,” Johan Bjorklund, co-CEO of Aiberry, said in a statement.
Wave Life, a mental health platform for Gen Z, has raised a $6 million seed investment led by Santé Ventures.
Hannah Grey, Gaingels, Telocity Ventures and Joyance Capital also participated in the round.
The California-based company offers on-demand virtual mental health coaching for individuals and employers aimed at the Gen Z population, as well as a mental health coaching certification and training program.
It will use the funds to refine its product offering and expand into the employer space.